Gilead Says U.S. Medicare Negotiated Price For HIV Drug Biktarvy Set At $2,600 Per 30-Day Supply From Jan. 1, 2028; Says Price Represents Approximately 38% Discount To Medicare List Price; Sees About $1.5 Billion Hit In 2028 From Lower Biktarvy Prices In Medicare

뉴스 본문을 불러오고 있어요.

Gilead Says U.S. Medicare Negotiated Price For HIV Drug Biktarvy Set At $2,600 Per 30-Day Supply From Jan. 1, 2028; Says Price Represents Approximately 38% Discount To Medicare List Price; Sees About $1.5 Billion Hit In 2028 From Lower Biktarvy Prices In Medicare | 웨이프 WAPE

Gilead Says U.S. Medicare Negotiated Price For HIV Drug Biktarvy Set At $2,600 Per 30-Day Supply From Jan. 1, 2028; Says Price Represents Approximately 38% Discount To Medicare List Price; Sees About $1.5 Billion Hit In 2028 From Lower Biktarvy Prices In Medicare

기사 요약

관련 종목

댓글 —